Sominone improves memory impairments and increases axonal density in Alzheimer's disease model mice, 5XFAD

International Journal of Neuroscience

Volumn 121, Issue 4, 2011, Pages 181-190

  Joyashiki, Eri ^a   Matsuya, Yuji ^a   Tohda, Chihiro ^a  

^a UNIVERSITY OF TOYAMA   (Japan)

Author keywords

5XFAD; Alzheimer's disease; axon; object recognition memory; sominone

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; SAPOGENIN; SOMINONE; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; AMYLOID PLAQUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL COUNT; CONTROLLED STUDY; FRONTAL CORTEX; HIPPOCAMPUS; IMMUNOCYTOCHEMISTRY; MEMORY DISORDER; MICROGLIA; MOUSE; NERVE FIBER; NONHUMAN; PARIETAL CORTEX; RECOGNITION;

ALZHEIMER DISEASE; ANIMALS; AXONS; CELL COUNT; CELLS, CULTURED; CEREBRAL CORTEX; DEHYDROEPIANDROSTERONE; DISEASE MODELS, ANIMAL; HUMANS; MEMORY DISORDERS; MICE; MICE, TRANSGENIC; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS;

EID: 79951883328     PISSN: 00207454     EISSN: 15635279     Source Type: Journal    
DOI: 10.3109/00207454.2010.541571     Document Type: Article

References (25)

1. Braak, H., R̈ub, U., Schultz, C., & Del Tredici, K. (2006). Vulnerability of cortical neurons to Alzheimer's and Parkinson's diseases. Journal of Alzheimers Disease, 9(3 Suppl), 35-44. (Pubitemid 44253296)
2. Consales, C., Volpicelli, F., Greco, D., Leone, L., Colucci-D'Amato, L., Perrone-Capano, C., et al. (2007). GDNF signaling in embryonic midbrain neurons in vitro. Brain Research, 1159, 28-39. (Pubitemid 47058026)
3. Dickson, T. C., & Vickers, J. C. (2001). The morphological phenotype of β-amyloid plaques and associated neuritic changes in Alzheimer's disease. Neuroscience, 105, 99-107. (Pubitemid 32722097)
4. Eriksen, J. L., & Janus, C. G. (2007). Plaques, tangles, and memory loss in mouse models of neurodegeneration. Behavioral Genetics, 7, 79-100. (Pubitemid 46150856)
5. Grace, E. A., Rabiner, C. A., & Busciglio, J. (2002). Characterization of neuronal dystrophy induced by fibrillar amyloid beta: Implications for Alzheimer's disease. Neuroscience, 114, 265-273. (Pubitemid 35247506)
6. Henry, D. B., May, P. C., Dean, R. A., & Siemers, E. R. (2009). Development of semagacestat (LY450139), a functional gamma-secretase inhibitor, for the treatment of Alzheimer's disease. Expert Opinion of Pharmacotherapy, 10, 1657-1664.
7. Heredia, L., Helguera, P., de Olmos, S., Kedikian, G., Solá Vigo, F., LaFerla, F. et al. (2006). Phosphorylation of actin-depolymerizing factor/cofilin by LIM-kinase mediates amyloid beta-induced degeneration: A potential mechanism of neuronal dystrophy in Alzheimer's disease. Journal of Neuroscience, 26, 6533-6542. (Pubitemid 44318334)
8. Hu, X., Shi, Q., Zhou, X., He, W., Yi, H., Yin, X., et al. (2007). Transgenic mice overexpressing reticulon 3 develop neuritic abnormalities. EMBO Journal, 26, 2755-2767. (Pubitemid 46884276)
9. Jawhar, S., Trawicka, A., Jenneckens, C., Bayer, T. A., & Wirths, O. (2010). Motor deficits, neuron loss, and reduced anxiety coinciding with axonal degeneration and intraneuronal Abeta aggregation in the 5XFAD mouse model of Alzheimer's disease. Neurobiology of Aging, Epub ahead of print.
10. Knowles, R.B., Wyart, C., Buldyrev, S.V., Cruz, L., Urbanc, B., Hasselmo, M.E., et al.et al. (1999). Plaque-induced neurite abnormalities: Implications for disruption of neural networks in Alzheimer's disease. Proceedings of the National Academy of Sciences USA, 96, 5274-5279.
11. Kuboyama, T., Tohda, C., & Komatsu, K. (2005). Neuritic regeneration and synaptic reconstruction induced by withanolide A. British Journal of Pharmacology, 144, 961-971. (Pubitemid 40593022)
12. Kuboyama, T., Tohda, C., & Komatsu, K. (2006). Withanoside IV and its active metabolite, sominone, attenuate Aβ (25-35)-induced neurodegeneration. European Journal of Neuroscience, 23, 1417-1426.
13. Matsuya, Y., Yamakawa, Y., Tohda, C., Teshigawara, K., Yamada, M., & Nemoto, H. (2009). Synthesis of sominone and its derivatives based on an RCMstrategy: Discovery of a novel anti-Alzheimer's disease medicine candidate "denosomin". Organic Letters, 11, 3970-3973.
14. Oakley, H., Cole, S. L., Logan, S., Maus, E., Shao, P., Craft, J. et al. (2006). Intraneuronal beta-amyloid aggregates, neurodegeneration, and neuron loss in transgenic mice with five familial Alzheimer's disease mutations: Potential factors in amyloid plaque formation. Journal of Neuroscience, 26, 10129-10140. (Pubitemid 44527407)
15. Ohno, M., Chang, L., Tseng, W., Oakley, H., Citron, M., Klein, W. L., et al. (2006). Temporal memory deficits in Alzheimer's mouse models: rescue by genetic deletion of BACE1. European Journal of Neuroscience, 23, 251-260.
16. Ohno, M. (2009). Failures to reconsolidate memory in a mouse model of Alzheimer's disease. Neurobiology of Learning and Memory, 92, 455-459.
17. Ohno, M., Cole, S. L., Yasvoina, M., Zhao, J., Citron, M., Berry, R., et al. (2007). BACE1 gene deletion prevents neuron loss and memory deficits in 5XFAD APP/PS1 transgenic mice. Neurobiology of Disease, 26, 134-145. (Pubitemid 46436493)
18. Salloway, S., Sperling, R., Gilman, S., Fox, N.C., Blennow, K., Raskind, M. et al. (2009). A phase 2 multiple ascending dose trial of bapineuzumab in mild to moderate Alzheimer disease. Neurology, 73, 2061-2070.
19. Terry, R. D., Masliah, E., Salmon, D. P., Butters, N., DeTeresa, R., Hill, R. et al. (1991). Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Annals of Neurology, 30, 572-580.
20. Tohda, C., & Joyashiki, E. (2009). Sominone enhances neurite outgrowth and spatial memory mediated by the neurotrophic factor receptor, RET. British Journal of Pharmacology, 157, 1427-1440.
21. Tohda, C., Kuboyama, T., & Komatsu, K. (2005). Search for natural products related to regeneration of the neuronal network. Neurosignals, 14, 34-45. (Pubitemid 40868982)
22. Tohda, C., Matsumoto, N., Zou, K., Meselhy, M.R., & Komatsu, K. (2004). Aβ(25-35)-induced memory impairment, axonal atrophy, and synaptic loss are ameliorated by M1, A metabolite of protopanaxadiol-type saponins. Neuropsychopharmacology, 29, 860-868.
23. Tohda, C., Tamura, T., & Komatsu, K. (2003). Repair of amyloid β(25-35)-induced memory impairment and synaptic loss by a Kampo formula, Zokumei-to. Brain Research, 990, 141-147.
24. Tsai, J., Grutzendler, J., Duff, K., & Gan, W.B. (2004). Fibrillar amyloid deposition leads to local synaptic abnormalities and breakage of neuronal branches. Nature Neuroscience, 7, 1181-1183. (Pubitemid 39426234)
25. Wu, H. Y., Hudry, E., Hashimoto, T., Kuchibhotla, K., Rozkalne, A., Fan, Z. et al. (2010). Amyloid β induces the morphological neurodegenerative triad of spine loss, dendritic simplification, and neuritic dystrophies through calcineurin activation. Journal of Neuroscience, 30, 2636-2649.